Discover

KVUE
Kenvue Inc.
19.06
18600 x 19.00
7800 x 19.12
bid
ask
+
0.13
0.69%
13200 @ 08:00 PM
19.01 -0.05 (0.26%)
Ytd10.49%
1y-11.10%
18.87
day range
19.16
14.02
52 week range
21.63
Open18.97Prev Close18.93Low18.87High19.16Mkt Cap36.61B
Vol11.01MAvg Vol20.81MEPS0.85P/E22.42Forward P/E15.41
Beta0.43Short Ratio3.41Inst. Own95.94%Dividend0.84Div Yield4.44
Ex Div Date08-12Earning11-0550-d Avg19.02200-d Avg17.831yr Est19.50
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-022026-090.28N/AN/AN/A
2026-08-062026-060.320.31-0.01-2.73%
2026-05-072026-030.260.320.0622.09%
2026-02-172025-120.220.270.0521.24%
2025-11-032025-090.260.280.027.61%
2025-08-072025-060.280.290.012.95%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-11UBSUpgradeNeutralNeutral
2026-07-21BarclaysUpgradeEqual-WeightEqual-Weight
2026-07-16UBSUpgradeNeutralNeutral
2026-04-15CitigroupUpgradeNeutralNeutral
2026-04-14BarclaysUpgradeEqual-WeightEqual-Weight
2026-04-07UBSUpgradeNeutralNeutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
DateNameRelationQuantityDescription
2026-03-09ALVARADO LUANIChief Operating Officer61.42KConversion of Exercise of derivative security
2026-03-09LAWSON CARLTONOfficer111.42KConversion of Exercise of derivative security
2025-03-04MEURER JANOfficer33.18KConversion of Exercise of derivative security
2025-03-04MONGON THIBAUTChief Executive Officer216.47KConversion of Exercise of derivative security
2025-12-14PERRY KIRK LChief Executive Officer62.55KConversion of Exercise of derivative security
2025-03-04RUH PAULChief Financial Officer56.20KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29FMR, LLC157.05M2.99B8.18%
2026-06-29Blackrock Inc.150.83M2.87B7.85%
2026-06-29Vanguard Capital Management LLC125.31M2.39B6.52%
2026-06-29State Street Corporation121.62M2.32B6.33%
2026-06-29Vanguard Portfolio Management LLC93.30M1.78B4.86%
2026-06-29Geode Capital Management, LLC52.02M991.01M2.71%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund60.84M1.16B3.17%
2026-03-30VANGUARD INDEX FUNDS-Vanguard 500 Index Fund48.69M927.53M2.53%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund41.39M788.55M2.16%
2026-06-29iShares Trust-iShares Core S&P 500 ETF26.49M504.71M1.38%
2026-06-29Fidelity Concord Street Trust-Fidelity 500 Index Fund24.63M469.21M1.28%
2026-06-29SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust23.21M442.07M1.21%
Dividend
DividendDate
0.212026-08-12
0.20752026-05-13
0.20752026-02-11
0.20752025-11-12
0.20752025-08-13
0.2052025-05-14